Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Proposes Share Number Increase, Reverse Stock Split

NEW YORK(GenomeWeb) – Nanosphere said after the close of the market on Tuesday that it will hold a special shareholders' meeting next month to vote on proposals by the firm to increase the number of its shares and to carry out a reverse stock split in order to regain compliance with Nasdaq listing requirements. 

During the April 7 meeting, shareholders will vote on whether to approve Nanosphere's request to increase its share number to 250 million from 150 million. Shareholders will also vote on whether to effect a reverse stock split of its issued and outstanding common shares with a ratio in the range of between 15-to-one and 25-to-one, with the exact ratio to be determined by Nanosphere's board. 

The company is making the proposals in order to regain compliance with a Nasdaq listing requirement calling for a minimum $1 bid price. The Nasdaq warned the company about its non-compliance in September. 

Shares of Nanosphere were down more than 19 percent in Wednesday morning trading at $.20.

The Scan

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.

Meta AI Computer Model Rapidly Predicts Hundreds of Millions of Metagenomic Proteins

Meta AI researchers describe in Science a new large language model that can predict the structures of millions of metagenomic proteins.

Hutch Team Develops Platform for Assessing Impact of SARS-CoV-2 Spike Mutations

The approach described in Cell relies on lentiviral pseudotyping for mutational scanning, which the researchers applied to the SARS-CoV-2 spike protein.

Potential New Therapeutic Target for Rheumatoid Arthritis Discovered

Researchers report in the American Journal of Human Genetics that SNPs implicated in rheumatoid arthritis often regulate the expression of the inflammation-related SPRED2 gene.